Who
Philippe Weigerstorfer
Director
Company insider
Files Form 4 as: Director, Sonoma Pharmaceuticals.
In numbers
- Trades disclosed
- 7
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 14 Jan 2022
- Last trade
- 9 Jul 2026
- Last filed
- 9 Jul 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Jul 2026filed 9 Jul 2026 | SNOA Sonoma Pharmaceuticalsoption or derivative · Medical Devices | SEC FORM 4 Code A | —10,000 | filing |
| 9 Jul 2026filed 9 Jul 2026 | SNOA Sonoma Pharmaceuticalsoption or derivative · Medical Devices | SEC FORM 4 Code A | —10,000 | filing |
| 2 Jan 2026filed 2 Jan 2026 | SNOA Sonoma Pharmaceuticalsoption or derivative · Medical Devices | SEC FORM 4 Code A | —10,000 | filing |
| 2 Jan 2026filed 2 Jan 2026 | SNOA Sonoma Pharmaceuticalsoption or derivative · Medical Devices | SEC FORM 4 Code A | —10,000 | filing |
| 2 Jan 2025filed 3 Jan 2025 | SNOA Sonoma Pharmaceuticalsoption or derivative · Medical Devices | SEC FORM 4 Code A | —7,500 | filing |
| 29 Dec 2022filed 30 Dec 2022 | SNOA Sonoma Pharmaceuticalsoption or derivative · Medical Devices | SEC FORM 4 Code A | —20,000 | filing |
| 14 Jan 2022filed 14 Jan 2022 | SNOA Sonoma Pharmaceuticalsoption or derivative · Medical Devices | SEC FORM 4 Code A | —30,000 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.